Početna › Kronična limfocitna leukemija › Oregon › Eugene
Kliničke studije za Kronična limfocitna leukemija u gradu Eugene, OR
6 studija za Kronična limfocitna leukemija traži sudionike na lokacijama u gradu Eugene i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
U tijeku regrutacijaFaza 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
U tijeku regrutacijaFaza 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
U tijeku regrutacijaFaza 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
U tijeku regrutacijaFaza 1/2
- Oncology Associates of Oregon, Eugene
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
U tijeku regrutacijaFaza 2
- Williamette Valley Cancer Institute & Research Center, Eugene
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
U tijeku regrutacijaFaza 3
- Willamette Valley Cancer Institute and Research Center /ID# 266326, Eugene
Studije za Kronična limfocitna leukemija u drugim gradovima
- Boston, MA31 studija
- Columbus, OH28 studija
- Durham, NC27 studija
- Washington, DC22 studija
- Seattle, WA20 studija
- Rochester, MN19 studija
- New York City, NY18 studija
- Houston, TX17 studija
- Baldwin Park, CA16 studija
- Milwaukee, WI15 studija
- Cincinnati, OH14 studija
- Chicago, IL14 studija
Ostale studije u gradu Eugene
- Nemikrocelularni karcinom pluća13 studija
- Rak jajnika9 studija
- Rak endometrija8 studija
- Rak dojke7 studija
- Multipli mijelom6 studija
- Metastatski karcinom6 studija
- Rak (sve vrste)6 studija
- Upotreba lijekova i ovisnost5 studija
- Rak pluća5 studija
- Makularna degeneracija5 studija
- Debljina4 studija
- Rak prostate3 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.